| Gene symbol | LILRB4 | Synonyms | B4, CD85K, ILT-3, ILT3, LIR-5, LIR5 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.42 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | leukocyte immunoglobulin like receptor B4 | ||||
| GTO ID | GTC0969 |
| Trial ID | ChiCTR2200056409 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | LILRB4 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | lilrb4 CAR-T cells |
| Phase | Phase2 |
| Recruitment status | Not Recruiting |
| Title | Prospective clinical study of the safety and efficacy of anti-LILRB4 CAR-T therapy in relapsed and refractory acute myeloid leukemia |
| Year | 2022 |
| Country | China |
| Company sponsor | Affiliated Hospital of Xuzhou Medical University |
| Cohort 1 | |||||||
|
|||||||